Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates

Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic's AI Discovery Tools to Pursue New Drug Candidates GlobeNewswire July 09, 2025 Custom-built model will be trained using Revolution Medicines' proprietary data to discover novel drug candidates Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone […]

Robert Half receives four Canadian HR Reporter Readers’ Choice Awards 2025, for 10th consecutive year

Global talent solutions and business consulting firm Robert Half is proud to receive four Canadian HR ReporterReaders' Choice Awards 2025, winning in the following categories: Compensation Survey/Salary Forecast, Executive Recruitment Agency, Recruitment Agency, and Specialized Recruitment Agency (Marketing & Creative Talent Solutions). 2025 marks Robert Half's 10th consecutive year as a recipient of Canadian HR

Dr. Anosh Ahmed Plans $25,000 Donation to Support FBI Families and Law Enforcement Mental Health Programs

Dr. Anosh Ahmed Plans $25,000 Donation to Support FBI Families and Law Enforcement Mental Health Programs Chicago-based physician to contribute through Anosh Inc Foundation and host local fundraiser in support of federal agents GlobeNewswire July 09, 2025 Image by Dr. Anosh Ahmed CHICAGO, July 09, 2025 (GLOBE NEWSWIRE) — Dr. Anosh Ahmed, a Chicago-based physician

Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway

Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway GlobeNewswire July 09, 2025 Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runway Dr. Edwin Tucker departing as Chief Medical Officer; Dr. Daniel Adelman to serve as Acting Chief Medical Officer REDWOOD CITY, Calif., July

Oportun Issues Letter Urging Stockholders to Vote for Director Nominees Raul Vazquez and Carlos Minetti

Oportun Issues Letter Urging Stockholders to Vote for Director Nominees Raul Vazquez and Carlos Minetti Notes Findell Capital Has Quietly Sold 500,000 Shares of Stock While Publicly Urging Others To Buy GlobeNewswire July 09, 2025 SAN CARLOS, Calif., July 09, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT) (“Oportun” or the “Company”), a mission-driven financial services

Ziggy Buys Houses Announces Nationwide ‘WE BUY HOUSES FOR CASH!’ Services

Ziggy Buys Houses Announces Nationwide 'WE BUY HOUSES FOR CASH!' Services GlobeNewswire July 09, 2025 Aurora, CO, July 09, 2025 (GLOBE NEWSWIRE) — Ziggy Buys Houses is excited to announce the launch of its nationwide 'WE BUY HOUSES FOR CASH' services, which have been expertly created by a team of experienced, ethical home buyers to

Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500%

Sunny Mining launches DOGE/BTC short-term contracts, with weekly new user registrations increasing by 500% Mounting momentum in North America as Sunny Mining's new fixed-income cloud mining contracts spark 500% surge in weekly registrations, backed by eco-friendly infrastructure and effortless daily returns. GlobeNewswire July 09, 2025 Los Angeles, California, July 09, 2025 (GLOBE NEWSWIRE) — GlobeNewswire

TopFX Expands Asset Offerings with Synthetic Indices Access

TopFX Expands Asset Offerings with Synthetic Indices Access GlobeNewswire July 09, 2025 Mahé, Seychelles, July 09, 2025 (GLOBE NEWSWIRE) — TopFX has now made synthetic indices trading available to all clients through its cTrader platform, marking a turning point for those who prefer structure, speed, and simplicity in the markets. This new addition allows traders

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces Oral MC4R Agonist Bivamelagon Achieved Statistically Significant, Clinically Meaningful BMI Reductions in Placebo-controlled Phase 2 Trial in Acquired Hypothalamic Obesity GlobeNewswire July 09, 2025 — Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks — — Post-hoc analysis

Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING

Finding certainty in market turmoil: Why more and more investors choose SAVVY MINING GlobeNewswire July 09, 2025 London, UK, July 09, 2025 (GLOBE NEWSWIRE) — With Solana (SOL) continuing to expand in the blockchain field, Ripple (XRP) being widely used in cross-border payments in Asia, and Dogecoin (DOGE) regaining the attention of retail investors, the

Scroll to Top